Publications by authors named "Miyuki Furuya"
Aims/introduction: Although patient self-efficacy is known to affect adherence to therapy, no available tool measures self-efficacy of insulin therapy administration while addressing the entire therapeutic process and management. In light of this, we developed the 'Insulin Therapy Self-efficacy Scale (ITSS).'
Materials And Methods: Development of the ITSS involved three phases: (i) item generation and creation of a questionnaire draft; (ii) testing and correcting the items through interviews with patients; and (iii) a multicenter, single-arm study to validate the questionnaire.
Aims: To assess the association between dipstick hematuria and estimated glomerular filtration rate (eGFR) decline in Japanese patients with type 2 diabetes.
Methods: Longitudinal data were obtained from 3068 Japanese patients with type 2 diabetes. To assess the independent association between dipstick hematuria and eGFR decline, we used Cox proportional hazard model adjusted for potential confounders.
Aims/introduction: We investigated the association between four insulin regimens, and increase in glycated hemoglobin (HbA1c) and insulin dose in a real-life clinical setting because there are no data about them among insulin regimens.
Materials And Methods: Participants included 757 patients with type 2 diabetes having been treated with insulin therapy for more than 1 year. The four insulin regimens were regimen 1 (long-acting insulin, once daily), regimen 2 (biphasic insulin, twice daily), regimen 3 (biphasic insulin, three times daily) and regimen 4 (basal-bolus therapy).
The aim of the present study was to investigate the prevalence of fear of hypoglycemia, in association with severe hypoglycemia and social factors, in insulin-treated patients with type 2 diabetes mellitus. A questionnaire survey on hypoglycemia and patient-physician communication was carried out in 355 patients with insulin-treated type 2 diabetes mellitus patients at 16 hospitals and clinics. A fear of hypoglycemia was reported by 27.
View Article and Find Full Text PDFAims: We investigated the association between diabetes treatment-related quality of life (QOL) and levels of self-care activities in insulin injection among Japanese patients with type 2 diabetes.
Methods: Data from 1394 patients with type 2 diabetes on insulin therapy were obtained from a diabetes registry in Japan. We used the Diabetes Therapy-Related QOL (DTR-QOL) questionnaire and relative risk regression analysis to assess the independent association of high levels of self-care activities in insulin injection and DTR-QOL scores while adjusting for possible confounders.
Article Synopsis
- * He also had a long history of Crohn's disease and a psychiatric disorder, which contributed to his health complications.
- * After switching to liraglutide treatment, his glycemic control significantly improved, lowering his HbA1c from 11.3% to 5.5% and enhancing his quality of life without causing hypoglycemic episodes.
Glucagon underutilized among type 1 diabetes mellitus patients in Japan.
Diabetes Technol Ther
September 2013
Aim: Glucagon is recommended to treat severe hypoglycemia in nonhospital environments, when a patient with type 1 diabetes mellitus (T1DM) is unconscious and unable to eat or drink. However, the actual possession rate of glucagon in Japan has not been investigated.
Subjects And Methods: We recruited 208 T1DM patients older than 15 years of age.
Article Synopsis
- The study aimed to examine how well patients with type 2 diabetes in Japan adhered to their insulin regimens and its impact on glycemic control.
- Researchers analyzed data from 1,441 insulin-treated patients, finding that 70.6% reported high adherence, and those with higher adherence had a better chance of maintaining good glycemic control compared to those with lower adherence.
- The positive association between adherence and glycemic control was significant in patients under 65 but not in those 65 and older, suggesting the need for more research on insulin dosing adjustments based on self-reported adherence among younger patients.
Article Synopsis
- A study aimed to identify factors that influence the effectiveness of basal-supported oral therapy (BOT) on lowering HbA1c levels in insulin-naive type 2 diabetic patients with poor glycemic control.
- The research involved 60 patients starting insulin glargine, analyzing relationships between baseline HbA1c, HbA1c after 24 weeks, duration of diabetes, and oral antidiabetic medications.
- Results showed that both the duration of diabetes and baseline HbA1c levels were significant predictors for HbA1c after 24 weeks, leading to a regression equation that helps estimate future HbA1c levels, supporting early BOT initiation for better glycemic control.